149 related articles for article (PubMed ID: 11584679)
1. [Monocrotaline induce pulmonary hypertension in animal models].
Alexandru B; Bogdan MA
Pneumologia; 2001; 50(2):85-9. PubMed ID: 11584679
[TBL] [Abstract][Full Text] [Related]
2. Chronic pulmonary hypertension--the monocrotaline model and involvement of the hemostatic system.
Schultze AE; Roth RA
J Toxicol Environ Health B Crit Rev; 1998; 1(4):271-346. PubMed ID: 9776954
[TBL] [Abstract][Full Text] [Related]
3. Effects of monocrotaline pyrrole on cultured rat pulmonary endothelium.
Hoorn CM; Wagner JG; Roth RA
Toxicol Appl Pharmacol; 1993 Jun; 120(2):281-7. PubMed ID: 8511798
[TBL] [Abstract][Full Text] [Related]
4. Short-term administration of a cell-permeable caveolin-1 peptide prevents the development of monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy.
Jasmin JF; Mercier I; Dupuis J; Tanowitz HB; Lisanti MP
Circulation; 2006 Aug; 114(9):912-20. PubMed ID: 16940204
[TBL] [Abstract][Full Text] [Related]
5. Lactate dehydrogenase activity and isozyme patterns in tissues and bronchoalveolar lavage fluid from rats treated with monocrotaline pyrrole.
Schultze AE; Gunaga KP; Wagner JG; Hoorn CM; Moorehead WR; Roth RA
Toxicol Appl Pharmacol; 1994 Jun; 126(2):301-10. PubMed ID: 8209383
[TBL] [Abstract][Full Text] [Related]
6. Cellular fibronectin and von Willebrand factor concentrations in plasma of rats treated with monocrotaline pyrrole.
Schultze AE; Emeis JJ; Roth RA
Biochem Pharmacol; 1996 Jan; 51(2):187-91. PubMed ID: 8615888
[TBL] [Abstract][Full Text] [Related]
7. 2-Methoxyestradiol mediates the protective effects of estradiol in monocrotaline-induced pulmonary hypertension.
Tofovic SP; Zhang X; Jackson EK; Dacic S; Petrusevska G
Vascul Pharmacol; 2006 Dec; 45(6):358-67. PubMed ID: 16872912
[TBL] [Abstract][Full Text] [Related]
8. Strain differences in the response of Fischer 344 and Sprague-Dawley rats to monocrotaline induced pulmonary vascular disease.
Pan LC; Wilson DW; Segall HJ
Toxicology; 1993 Mar; 79(1):21-35. PubMed ID: 8475497
[TBL] [Abstract][Full Text] [Related]
9. Genistein, a phytoestrogen, attenuates monocrotaline-induced pulmonary hypertension.
Homma N; Morio Y; Takahashi H; Yamamoto A; Suzuki T; Sato K; Muramatsu M; Fukuchi Y
Respiration; 2006; 73(1):105-12. PubMed ID: 16432296
[TBL] [Abstract][Full Text] [Related]
10. PRX-08066, a novel 5-hydroxytryptamine receptor 2B antagonist, reduces monocrotaline-induced pulmonary arterial hypertension and right ventricular hypertrophy in rats.
Porvasnik SL; Germain S; Embury J; Gannon KS; Jacques V; Murray J; Byrne BJ; Shacham S; Al-Mousily F
J Pharmacol Exp Ther; 2010 Aug; 334(2):364-72. PubMed ID: 20430844
[TBL] [Abstract][Full Text] [Related]
11. [Role of leukotriene B4 in monocrotaline-induced pulmonary hypertension].
Tabata T; Ono S; Song C; Noda M; Suzuki S; Tanita T; Fujimura S
Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Feb; 35(2):160-6. PubMed ID: 9103852
[TBL] [Abstract][Full Text] [Related]
12. [Effects of various doses of monocrotaline administration on the development of pulmonary hypertension and its regression in rats].
Kakusaka I; Kaneko N; Kiyatake K; Fujita A; Suzuki A; Nakano K; Okada O; Sugita T; Watanabe S; Kuriyama T
Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Jan; 27(1):51-6. PubMed ID: 2501548
[TBL] [Abstract][Full Text] [Related]
13. COR pulmonale is caused by monocrotaline and dehydromonocrotaline, but not by glutathione or cysteine conjugates of dihydropyrrolizine.
Pan LC; Wilson DW; Lamé MW; Jones AD; Segall HJ
Toxicol Appl Pharmacol; 1993 Jan; 118(1):87-97. PubMed ID: 8430429
[TBL] [Abstract][Full Text] [Related]
14. Fibrinolytic activity in blood and lungs of rats treated with monocrotaline pyrrole.
Schultze AE; Roth RA
Toxicol Appl Pharmacol; 1993 Jul; 121(1):129-37. PubMed ID: 7687795
[TBL] [Abstract][Full Text] [Related]
15. [Monocrotaline-induced pulmonary hypertension in animals].
Tanino Y
Nihon Rinsho; 2001 Jun; 59(6):1076-80. PubMed ID: 11411116
[TBL] [Abstract][Full Text] [Related]
16. The response of pulmonary vascular endothelial cells to monocrotaline pyrrole: cell proliferation and DNA synthesis in vitro and in vivo.
Lappin PB; Ross KL; King LE; Fraker PJ; Roth RA
Toxicol Appl Pharmacol; 1998 May; 150(1):37-48. PubMed ID: 9630451
[TBL] [Abstract][Full Text] [Related]
17. Procoagulant and fibrinolytic properties of bovine endothelial cells treated with monocrotaline pyrrole.
Schultze AE; Roth RA
Toxicol Appl Pharmacol; 1993 Sep; 122(1):7-15. PubMed ID: 8378934
[TBL] [Abstract][Full Text] [Related]
18. Characterization of erectile function in monocrotaline-treated pulmonary hypertensive rats.
Gur S; Kadowitz PJ; Thammasitboon S; Lasky JA; Hellstrom WJ
J Androl; 2009; 30(5):495-504. PubMed ID: 19201699
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II and monocrotaline-induced pulmonary hypertension: effect of losartan (DuP 753), a nonpeptide angiotensin type 1 receptor antagonist.
Cassis LA; Rippetoe PE; Soltis EE; Painter DJ; Fitz R; Gillespie MN
J Pharmacol Exp Ther; 1992 Sep; 262(3):1168-72. PubMed ID: 1527721
[TBL] [Abstract][Full Text] [Related]
20. [Effects of prostaglandin E1 (PGE1) on pulmonary hypertension and lung vascular remodeling in a rat monocrotaline model of human pulmonary hypertension].
Ono S; Tanita T; Hoshikawa Y; Song C; Maeda S; Tabata T; Noda M; Ueda S; Ashino Y; Fujimura S
Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Aug; 33(8):862-7. PubMed ID: 7474567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
